AGL.L
ANGLE plc
1W: -0.9%
1M: -7.8%
3M: -47.7%
YTD: -10.4%
1Y: -92.9%
3Y: -96.8%
5Y: -98.9%
£0.94 ($0.01)
-0.01 (-1.05%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap£3.0M ($0.0M)
52W Range0.85-17.445
Volume1,396,024
Avg Volume2,390,337
Beta0.08
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAndrew David William Newland ACA, Meng
Employees150
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2004-03-17
Websiteangleplc.com
Surrey Research Park
Guildford GU2 7AF
GB
Guildford GU2 7AF
GB
44 14 8334 3434
About ANGLE plc
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Recent Insider Trades
No insider trades found